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Term Abbreviation 
TRP Tyrosinase-related protein 
MITF Microphthalmia-associated transcription 
factor 
α-MSH Melanocyte-stimulating hormone 
MC1-R Melanocortin-1 receptor 
POMC Proopiomelanocortin 
cAMP Cyclic adenosine monophosphate 
CREB cAMP response element 
ACTH Adrenocorticotropic hormone 
PKA Protein kinase A 
PKC-β Protein kinase C-β 
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GSK-3β 
 
Glycogen synthase kinase-3β 
(TCF) T-cell factor 
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IP3/DAG Inositol triphosphate/diacylglycerol 
(ERK) Extracellular signal-regulated kinase 
UVR Ultraviolet radiation 
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Abstract : 
 
     An investigation of the concentrations of Calcium in the 
black and gray hairs of the same person less than 30 year old in 
Khartoum North together with a control group was performed 
using Atomic absorption spectrophotometer . 
      The results of mineral element concentration determinations 
were evaluated by statistical analysis. My findings revealed that 
concentrations of Calcium in gray hair were higher than those in 
black hair . Concentrations of  calcium  showed significant 
differences between the two kinds of hair ( p < 0.05 ) . 
    Bone diseases related to calcium such as osteoporosis were 
not detected . 
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 -المستخلص :
 
فييييي  لييييي و اليراسيييييي مالقييييي  امريييييي  فييييي  م   يييييي ال ر يييييو  ب ييييير               
تيييييم تيييييياك تريييييييا الرالسييييييو  فييييي  الذييييي ر الاسيييييو  مالذييييياي  مالميييييا و  مييييين 
سيييي ي مييييا اسييييق يا  ا يييي ا ا ييييرين  03نفييييخ الذيييي ق لمنمييييار اتيييي  ميييين 
 يمجموني ضبط .
حييييييييت تيييييييم اسيييييييق ي  مايييييييا  الامق يييييييا الييييييي ر  ل يييييييياك تريييييييييا          
متييييييي يذييييييف   ميييييين  ييييييلإح الق  ييييييي  ا ح ييييييا   ال قييييييا  الرالسيييييييو   متيميييييي  
ت يييييا ال قيييييا   نييييين ارتفيييييار نسيييييبي الرالسييييييو  فييييي  الذييييي رات البي يييييا  نييييين 
أظاييييييرت تريييييييياات الرالسيييييييو  فييييييرم  م  ويييييييي بييييييين الذيييييي رات السييييييو ا  م 
  . )50.0< p(   نون  الذ ر
ليييييم ييييييقم الرذيييييا نييييين اميييييراي ال ثيييييا  المق   يييييي بالرالسييييييو  م ييييي   م         
 . لذا ي ال ثا 
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1 – Introduction  
1-1 Hair : 
          Skin and hair color contribute significantly to our overall 
visual appearance and social communication. The color of hair 
relies on the presence or absence of melanins alone. The human 
hair follicles contain two types of melanins: the black-brown 
pigment eumelanins mainly present in black and brown hair and 
the yellow or red pheomelanins in auburn and blonde hair. [1] 
          In addition pigment lipids and trace elements, proteins 
mainly compose 65% to 95% of human hair. Most of this trace 
elements do not exist in hair alone , but bind with proteins or 
fatty acids . [2] 
1-1-2 Functions: 
          "Human beings are unique in having very thick, long, and 
highly pigmented scalp hair. This is likely to have provided one 
or more survival benefits to the humans. Firstly, selective and 
avid binding of toxins and metals to melanin pigment aids in 
preventing the buildup of toxic metals.[3]Secondly, reactive 
quinone intermediates generated during melanin synthesis 
possess potent antibacterial properties. Lastly, deep brown-black 
hair present in 90% of the world's population protects against 
sunstroke and its melanin aids very efficient and fast exchange 
of ion transport and efflux for adequate salt balance.[4]"and plays 
a crucial role in the absorption of the free radicals generated 
within the cytoplasm [5] . 
1-1-3  Melanin Synthesis : 
          The color of human hair depends on melanogenesis, the 
process of synthesis of melanin and its subsequent distribution 
from the melanocyte to keratinocyte. The process is thought to 
be regulated genetically at various levels[6]. 
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Both epidermal and follicular melanocytes are derived from 
immature melanoblasts that migrate from the neural crest into 
the skin during embryogenesis[6]. 
          The first, and rate-limiting, step of melanin synthesis is 
the conversion of tyrosine to DOPA and dopaquinone by the 
oxidating enzyme tyrosinase .This step is common to both 
eumelanin and pheomelanin synthesis [7] . 
          Eumelanogenesis involves the further transformation of 
dopaquinone to leukodopachrome, followed by a series of 
oxidoreduction reactions with production of the intermediates 
dihydroxyindole (DHI) and DHI carboxylic acid (DHICA), that 
undergo polymerization to form eumelanin[8,9]. 
          Pheomelanins which are initially synthesized just like 
eumelanins, but DOPA undergoes cysteinylation, directly or by 
the mediation of glutathione. The end product of this reaction, 
cysteinylDOPA, further polymerizes into various derivatives of 
benzothiazines[10] Figure 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Melanin Synthesis Adapted from:Wolff K et al 2007 . [11] 
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1-1- 4 Regulation of Melanogenesis : 
 
          Regulation of melanogenesis in mammals is controlled 
under stringent genetic  control at different levels and is 
complex at each  level  . [12,13] .Figure 2 shows 
          The  three most commonly known  signal pathways 
involved  in  the  regulation  of melanogenesis. All  three signal 
pathways involve  microphthalmia-associated transcription 
factor (MITF). 
          MITF is a basic helix-loop-helix (hHLH)-leucine zipper 
protein [14].Plays an important role in melanocyte development 
by regulating the expression of tyrosinase (TYR) and tyrosinase-
related protein 1 (TYRP1). Plays a critical role in the 
differentiation of various cell types, such as neural crest-derived 
melanocytes, and optic cup-derived retinal pigment epithelium. 
Some research indicates that melanogenesis associated 
transcription factor also regulates the development of cells that 
break down and remove bone (osteoclasts) and cells that play a 
Role in allergic reactions (mast cells) [15,16]. 
          Mutation of this gene results in deafness, bone loss, small 
eyes, and poorly pigmented eyes and skin [17] . 
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Figure  2.  Three common signal pathways involved  in  the  regulation of melanogenesis. 
(Modified  from melanogenesis pathway map of Kyoto Encyclopedia of Genes and 
Genomes) KEGG Pathway database
[18]
. Available online: 
http://www.genome.jp/kegg/pathway.html (accessed on 7 August 2012).  
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          The melanocortin-1 receptor (MC1R) is a seven 
transmembrane domain G protein-coupled receptor. It is 
expressed predominantly in melanocytes, they are activated by 
ligands derived from the precursor protein proopiomelanocortin 
(POMC) [19,20] . The predominant POMC derived ligand 
produced in skin cells is α-melanocyte stimulating hormone 
(αMSH), produced by melanocytes, keratinocytes, fibroblasts, 
endothelial cells and inflammatory cells [21] . Stimulation of the 
MC1R by αMSH leads to intracellular release of the GTPbound 
 subunit, which then activates adenylatecyclase to produce 
cAMP.  
          cAMP activates protein kinase A (PKA), which then 
activates the gene expression of MITF via phosphorylation of 
the cAMPresponse element-binding protein (CREB). Finally, 
MITF efficiently activates the melanogenesis-related enzymes 
and stimulates melanogenesis. Once α-MSH  binds to MC1R, up 
to  a  100-fold increase in melanogenesis  attends.  In addition to  
α-MSH, other POMC-derived peptides, such as  β-MSH and 
adrenocorticotropic hormone (ACTH), also stimulate 
melanogenesis via the same pathway.  
          Although POMC/MC1-R/cAMP is the main pathway, 
there are other melanocyte receptors associated with 
adenylcyclase and cAMP production, such as muscarinic 
receptors and α and β estrogen receptors The increase in 
estrogen levels during pregnancy can cause hyperpigmentation 
(melasma, areolar hyper pigmentation and  line 
nigricans[22]Catecholamines may be produced by keratinocytes 
from L-DOPA, the melanin precursor, and can bind to α1 and β2 
adrenergic receptors in melanocytes, stimulating melanogenesis 
via the cAMP pathway and PKC-β[23,24] This redundancy of 
cAMP production reveals the importance of this second 
messenger in melanogenesis However, norepinephrine/α1 
adrenergic receptor ACTH 1-17/MC1-R can also activate the 
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inositol trisphosphate/diacylglycerol (IP3/DAG) pathway which 
promotes the release of calcium in the cytoplasm of melanocytes 
[25,26,24]. 
          DAG is important for the activation of PKC-β, which 
phosphorylates tyrosinase and can also be released from 
]29,8,272[melanocytes through UVR action in the lipid membrane . 
          Another signal pathway also targeting the gene expression 
of MITF is the Wnt signal pathway. A key control in this 
pathway is the level of intracellular  β-catenin. In the absence of 
a Wnt signal,  β-catenin is  sequentially phosphorylated by 
glycogen synthase kinase-3β  (GSK-3β), and the phosphorylated 
β-catenin is recognized by an ubiquitin ligase complex, resulting 
in the degradation of β-catenin via an ubiquitin-dependent 
mechanism. In contrast, activation of the Wnt pathway 
negatively regulates GSK-3β, leading to the accumulation of 
cytoplasmic β-catenin, which translocates to nuclei and forms a 
complex with both T-cell factor (TCF) and lymphocyte 
enhancer factor-1 (LEF) to  up-regulate expression of the MITF 
gene [30,31,32] . Hence, activation of the Wnt pathway stimulates 
melanogenesis via the up-regulation of MITF activity.  
          In contrast to the regulation of gene expression of MITF 
by α-MSH and Wnt signal pathways, the extracellular signal-
regulated kinase (ERK) pathway regulates melanogenesis  via  
the degradation of the MITFprotein.[33] Previous studies have 
shown that ERK activation phosphorylates MITF at serine 73, 
which is followed by MITF ubiquitination and proteasome-
mediated degradation.[34,35] 
          Therefore, activation of the ERK pathway would inhibit 
melanogenesis due to the down-regulation of the MITF activity. 
In addition, some reports have emphasized the important roles 
of c-Kit in the ERK pathway  [36,37,38]. 
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1-2- Premature gray hair : 
1-2-1  Definition : 
          Hair is said to gray prematurely when it occurs before the 
age of 20 in whites, 25 in Asians and 30 in Africans.[39]  
 
1-2-2The etiology of premature hair graying:- 
          The etiology of premature hair graying is unknown. 
However, it is clear that melanocytesin hair follicles stop 
producing melanin. Impaired production of melanin (or 
premature melanocyte dropout) is inherited in an autosomal 
dominant pattern.[40] 
          Premature hair graying has also been associated with 
autoimmune disorders, as they occur in vitiligo (e.g. pernicious 
anemia, autoimmune thyroid disease) and several rare 
syndromes with premature aging (e.g. Werner’s syndrome). [41] 
          There is also some evidence that age is associated with 
increased graying in humans. [42]In addition, a link between 
smoking and gray hair in both men and women and between 
smoking and hair loss in men has been reported earlier.[43,44] 
         Trace element deficiencies lead to a spectrum of the 
clinical manifestations especially in skin and hair. Pigmentary 
changes and hair loss are important manifestations of deficiency 
states. Iron and vitamin B12 have been shown to affect hair 
growth and pigmentation.  
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         It has also been hypothesized that the premature graying is 
associated with osteopenia indicating a probable role for vitamin 
D3 and calcium. [45,46] 
        Based on previous clinical associations, the gene that codes 
for early graying is probably linked to one or more genes that 
control the expression of other traits or diseases. 
  1-2-3Premature Gray hair  as a Risk Factor for Systemic Disease : 
         Premature graying  hair have been proposed as potential 
markers for the identification of persons at risk for osteoporosis 
and  Coronary artery disease (CAD). 
1-2-3-1 Osteoporosis : 
1-2-3-1-1 Definition : 
 
         Osteoporosis is a systemic disease of the skeleton, 
characterized by reduction of bone mass and concurrent 
deterioration of bone structure. 
         Consequently, bones become more fragile and there is 
increased risk of fractures .[47,48,49] 
          All humans lose bone density starting between the ages of 
30 and 40. Excessive bone loss affects over 20 million people, 
mostly women who are 45 and older . 
 
 
1-2-3-1-2 Factors influencing peak bone mass : 
 
          A number of factors influence peak bone mass [47,48,49,50,51]. 
These include heredity, sex, nutrition, endocrine factors ( sex 
hormones, calcitriol), mechanical influences (physical activity, 
body mass) and some risk factors (smoking, excessive alcohol 
intake, etc.). Genetic factors influence mainly absorption of 
calcium from the intestine: gene responsible for the formation of 
vitamin D receptors has several variants, which have different 
effect on absorption of calcium. Genetic differences can 
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however be compensated for by adequate supply of calcium in 
diet[49] 
          Deposition of calcium into bones is also under the 
influence of sex hormones, testosterone in men, estrogens in 
women. Late puberty,childlessness, early menopause, secondary 
amenorrhoea and ovarectomy are risk factors for osteoporosis in 
women. 
 
1-2-3-1-3 Risk factor of Osteoporosis : 
1-2-3-1-3-1 Uncontrollable Risk Factors 
 Being over age 50.  
 Being female.  
 Menopause.  
 Family history of osteoporosis.  
 Low body weight/being small and thin.  
 Broken bones or height loss. 
1-2-3-1-3-2 Controllable Risk Factors 
 Not getting enough calcium and vitamin D. 
 Not eating enough fruits and vegetables. 
 Getting too much protein, sodium and caffeine. 
 Having an inactive lifestyle. 
 Smoking.  
 Drinking too much alcohol. 
 Losing weight. 
 
10 
 
 
Figure  3 Pathogenesis of osteoporotic fractures. Adapted from Riggs and Melton.
[52] 
 
1-2-3-2  Coronary artery disease (CAD) :  
 
          "Various authors have reported premature graying of hair 
to be a significant risk factor for coronary artery disease (CAD). 
[53,54].[55] Dwivediet al. reported that young CAD patients who 
are heavy smokers also developed premature graying and 
balding. They suggested that presence of premature hair graying 
in chronic smokers indicates higher than normal risk for 
CAD.[55] 
           Further, hair graying has recently been shown to be a 
marker of CAD independent of age and other traditional risk 
factors in a cohort of 213 men undergoing coronary 
angiography. [56]In the Copenhagen City Heart Study, Schnohret 
al. reported that risk of myocardial infarction was directly 
proportional to the extent of graying of hair in men. [53]"[4] 
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1-3 -The relationship between  calcium and premature gray 
hair and some light on the risk of developing  diseases 
relation calcium metabolism : 
          Calcium is the most abundant mineral in the human body 
and has several important functions. Calcium is one of the main 
components of bones and teeth and plays apart in nerve, muscle, 
and bone metabolism . It plays avital role in maintaining the 
function of the heart , kidney , and platelets and in protecting the 
blood vessels [57,58] . 
          Long term of calcium deficiency can lead to Osteoporosis. 
Calcium insufficiencies have also been correlated with incident 
cardiovascular symptoms, including angina, coronary 
insufficiency, myocardial infarction, transient ischemic attack, 
and stroke.[59] 
          Calcium insufficiency has been correlated with 
cardiovascular risk factors, such as obesity, metabolic 
syndrome, diabetes mellitus type 2 and smoking . 
          And There is evidence that poor calcium nutrition is a 
significant risk factor for total cancer incidence[25] and, in 
particular, for colorectal   and breast cancer. Low calcium intake 
may contribute to the development of renal, gastric, pancreatic, 
ovarian, endometrial, and lung cancer as well as multiple 
myeloma, though conclusive evidence is missing .[60] 
          Calcium has been involved in some steps of 
melanogenesis .calcium binds to melanin This buffering 
capacity as applied to calcium would imply a role for melanin in 
cell function, since calcium is a critical second messenger in 
pigmentation signaling, acting in the transfer of melanosome to 
keratinocytes, and in epithelial cell differentiation [61] 
          Calcium is relevant to a-MSH binding, to a-MSH 
activation of  adenylatecyclase. cAMP activates protein kinase 
12 
 
A (PKA), which then activates the gene expression of MITF via 
phosphorylation of the cAMP  response element-binding protein 
(CREB). Finally, MITF efficiently activates the melanogenesis-
related  enzymes and stimulates melanogenesis. 
          It already is clear a relation to calcium bone mass 
deficiency and cardiovascular risk factors as smoking is working 
on lack of bone mass and increase the risk of heart disease as 
that found that It also found that calcium deficiency leads to 
obesity which claim to increase the risk of heart disease. A few 
also studies have shown a relationship between bone mass and 
Premature gray hair  and heart disease in previous studies 
collection With each assume a relationship between calcium and 
premature gray hair .Figure 4  
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Figure 4 :The relationship between  calcium and premature gray 
hair and Other diseases . 
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1-4 - JUSTIFICATION 
          There are only a few epidemiological and investigative 
studies reported in the literature in relation to premature graying 
of the hair. In view of this, I will conduct this study in Sudanese 
male subjects in khartoum North . 
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1-5. OBJECTIVES 
1-5.1 General Objective: 
 To study the (calcium) in premature gray hair and 
Black hair (same persons)   and compare to non 
premature gray hair control group. 
1-5.2 Specific objectives: 
 To estimate (calcium) level.  
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2 – Literature Review : 
 
          There are only a few epidemiological and investigative 
studies reported in the literature in relation to premature graying 
of the hair. 
          Premature graying  hair have been proposed as potential 
markers for the identification of persons at risk for osteoporosis.  
Based on previous clinical associations, the gene that codes for 
early graying is probably linked to one or more genes that 
control the expression of other traits or diseases. The precise 
mechanism responsible for accretion of bone mass has not been 
clearly delineated. However, genetic factors are the strongest 
determinants of peak bone density and may well be important in 
determining rates of bone loss later in life.[72] 
          The association between premature graying and low bone 
mass could be related to genes that control peak bone mass or 
factors that regulate bone turnover. Premature graying of hair 
may be an important risk marker for osteopenia [71]. Asians and 
northern Europeans have a Significantly higher incidence of 
osteoporosis than do people with darker skin pigmentation  
[73,74]. Recent work by Morrison et al   [75] suggests that 
polymorphisms in common allelic variants of the vitamin D 
receptor may affect peak adult bone mass. This, in turn, could 
explain consistent racial differences in bone density.[40] 
          It has also been hypothesized that the premature graying 
is associated with osteopenia indicating a probable role for 
vitamin D3 and calcium .[45,46] 
          Recent work by Bhat et al was an Epidemiological study 
and Investigative Study of Premature Graying of Hair in higher 
Secondary and Pre-University School Children. The present 
study shows a genetic predisposition in premature graying of 
hair and relation between low Serum Ferritin, Serum Ca and 
17 
 
vitamin D3 levels. Among the various laboratory parameters 
Serum Ca, Serum Ferritinand vitamin D3 were low in patients 
with premature graying of hair. There was significant high 
number of vitamin D3 deficientand insufficient among the cases 
compared to the controls. [76] 
          The potential role of calcium pointed him again Yueh et 
al in the study, conducted in Taiwan to focus some of the 
minerals in the hair was found less than a metal levels in Gray 
hair as compared to the control Black hair of the same person . 
[69]
 although the roles of calcium until now not clear to his roles 
in melanogenesis. Calcium has been involved in some steps of 
melanogenesis. [77] 
          Calcium playing a major but complex role in the 
regulation of melanogenesis J.A. Buffey et al   suggest that 
calcium is relevant to a-MSH binding, to a-MSH activation of 
adenylatecyclase, to the termination of the cyclic AMP signal, to 
some step in postcyclic AMP synthesis and pretyrosinase 
activation, and also to some step in melanosome translocation 
and secretion. [78] 
          And found through studies that calcium is required for 
several steps in melanogenesis, having an apparently inhibitory 
effect on pre-tyrosinase activity in unstimulated cells, but also 
showing evidence of a positive role in cyclic AMP-stimulated 
tyrosinase activity, as well as a further possible inhibitory role in 
melanin movement or secretion.[78] 
          In addition, it has been shown that calcium binds to 
melanin with a high afﬁnity regulating the redox status of the 
melanocyte leading to prevention of oxidative stress by ROS [79] 
In fact calcium binds to melanin with the same afﬁnity as 
calmodulin [79] 
          This observation emphasises the function of melanin as an 
important free radical scavenger rather then a weak physical 
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UV-ﬁlter with an sun protection factor (SPF) between 2 and 3. 
Taken together, calcium is an important participant in the 
concept of melanogenesis.This is supported by a few studies of 
the use of calcium which has been proposed as a treatment for 
the treatment of premature graying . 
          "Pasricha et al reported successful use of 200 mg of 
calcium pantothenate daily in two girls having premature 
graying of hair. On a follow-up of 29 and 13 months, 
respectively, 300 and 1069 gray hair were counted to have got 
converted into black hair. Hair with a proximal black portion 
and a distal gray part were termed as converted hair. [80]" [4].In 
another study, Pasricha   used combined calcium pantothenate  
They found the combination calcium pantothenate to be more 
effective than calcium pantothenate used alone. [81] 
          Brandaleone et al however, used 200 mg of PABA with 
100 mg of calcium pantothenate (vitamin B5) and 50 g of 
brewer's yeast for 8 months to patients with gray hair without 
any success. also HERWICK, KERLAN used Twenty mg. of 
calcium pantothenate was administered daily for six months to 
27 white men and women with graying hair. Close observation 
of the hair of these individuals revealed no significant change 
[82] .Pavithran et al. reported PUVASOL to be effective in 
almost two-thirds of patients with premature graying. [83]. 
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3. SUBJECTS, MATERIALS AND METHODS:- 
3.1  Subjects : 
3.1.1 Study design: 
         The study   was a cross sectional study. 
3.1.2 study area: 
         Samples were collected from healthy Sudanese under 30 
years old suffering from premature canities, having a minimum 
of five gray hairs. Sample and control were collected from 
different areas of North Khartoum state from barber shops. 
3.1.3 Study Subjects: 
          Healthy Sudanese under 30 year old suffering from 
premature gray hair, having a minimum of five gray hairs. 
3.1.4 Sample size:  
 
          24 sample healthy Sudanese under 30 years old suffering 
from premature gray hair, having a minimum of five gray hair 
and 24 control same persons (black hair) and 15 apparently  
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healthy Sudanese male age matched were selected as a control ( 
non suffering from premature gray hair). 
 
3.2 MATERIALS : 
3.2.1 Questionnaire: 
          For each Male a questionnaire data form was filled in 
order to obtain information regarding : age , residence, tribe, and 
information about education, tobacco use . Family history of 
premature gray hair and  Diseases and exercise History and 
Dietary History.  
3.2.2 Chemicals: 
Deionized water (ultra-pure water) 
Concentrated ultra-pure nitric acid (HNO3) ( 69-72%). 
Hclo4 ( 70% ) . 
 
3.2.3 Instruments: 
Analytical Balance SHIMADZU AY 220 Max 220g d= 0.1 mg . 
Atomic absorption spectrophotometer Model 210 VGP GAT # 
28750-15. 
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3.3 METHODS : 
3.3.1 Sample collection: 
 
         Two batches of black and gray hair samples were collected 
from the nape section of each healthy person .The age of less 
than 30 year males were provide samples of black and gray 
hairs.Hairs were cut near the scalp area with thin- blade stainless 
steel scissors. 
3.3.2 Sample cleaning : 
         Hair was washed with a water solution of detergent, free 
from metal ions, deionized water, and acetone.[84] 
 
3.3.3 Sample Digestion : 
          The hair weight and record the exact weight was taken in 
a 50 ml Beaker and digested with 10 ml of 6:1 mixture of 
concentrated ultra-pure nitric acid 69-72% and Hclo4 conc 70% 
and kept overnight at room temperature . The contents in the 
beaker were heated at 200 °C until dense white fumes are 
evolved . and  Digest hair until the hair is dissolved and the 
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solutions clear .  It was then transfered to volumetric flask and 
diluted with deionized water to volume 10ml .[85] 
3.3.4 Analytical technique: 
 The calcium was measured by Atomic absorption 
spectrophotometer Model 210 VGP GAT # 28750-15.  
3.3.5 Statistical analysis: 
 Statistical package for social sciences (IBM SPSS V.21) 
computer program, was used for analysis of data. 
 
 
3.4 Ethical consideration: 
 
          The objectives of the study were explained to all 
individuals participating in this study. 
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4 – Results  
 
Table 1 : Comparison between mean values of Concentrations 
in Black and Gray hair from the Same person and different 
person . 
 
 
Control 
       (n= 
15)Black hair  
Different person 
 (n= 24) 
Gray hair 
 
B (n=24) 
Black hair 
 
t 
value 
p value 
  
    
 
 
    
Concentration ( µg/g) 271.51  ± 216.56 1218.08  ± 2438.12 237.85  ± 158.129 -3.901- 0.031 
 
 
 
Data are expressed as mean ± standard deviation.  
NS= p> 0.05= not significant; p≤ 0.05= significant; p< 0.01= highly significant 
 
 
According to the t-test, we reject the null hypothesis.  There was 
enough evidence to suggest a significant difference between the 
mean values of Concentrations in Black and Gray hair from the 
Same person, t = -3.901-, p<.05. 
 
 
 
Same Person 
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Table (2) Address 
  Frequency Total Total 
Percent   control Sample  
Adress  0 0   
Aldroshab 10 15 25 64.1 
Halfia 0 2 2 5.1 
Kadero 0 1 1 2.6 
Shambat 3 2 5 12.8 
The station centrist bahri 2 4 6 15.4 
Total 15 24 39 100.0 
 
From table (2) and figure (1), 64.1% of  Sample size from Aldroshab and 15.4% 
The station centrist bahri and 12.8% from Shambat and 5.1% from Halfia and  
2.6 % from Kadero. 
 
 
 
 
Figure 1 : Frequency 
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Table(3) Age 
  
label Name Total 
Percent 
  control Sample Gray  Total 
Age 18-20 1 3 4 12.5 10.25 
21-23 5 3 8 12.5 20.5 
24-26 4 6 10 25 25.6 
27-29 5 12 17 50 43.6 
Total 15 24 39 
100.0 
From table (3),  50 % from age 27-29 yrs and 25% from age 24-26 yrs . 
 
 
Table(4) body mass index ( BMI) 
Sample N=24 Control N=15  
23.3±3.28119 22.1± 2.89135 BMI 
 
From table (4) and table (27) According to the Analysis of Variance, there were 
no significant differences between the BMI  groups in the mean  F(1.37 ) = 1.311 
p> 05. 
 
 
Table (5) Tribe 
  
label Name  percent 
  control Sample Total 
Tribe     Control sample Total 
Abdlab 0 2 2 0 8.3 5.1 
Arki 0 1 1 0 4.2 2.6 
Bedaria 1 3 4 6.7 12.5 10.3 
BeniAmer 0 1 1 0 4.2 2.6 
Btahin 1 0 1 6.7 0 2.6 
Houari 0 1 1 0 4.2 2.6 
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Hubab 0 1 1 0 4.2 2.6 
Jaalin 6 7 13 40 29.2 33.3 
Mahas 1 1 2 6.7 4.2 5.1 
Moroccans 0 1 1 0 4.2 2.6 
Nuba 1 0 1 6.7 0 2.6 
Rifai 1 0 1 6.7 0 2.6 
Rkabian 0 2 2 0 8.3 5.1 
Shaigiya 1 4 5 6.7 16.7 12.8 
Shukria 1 0 1 6.7 0 2.6 
The fur 1 0 1 6.7 0 2.6 
Zghavh 1 0 1 6.7 0 2.6 
Total 15 24 39 100 
 
 
From table (5) , 29.9% from Sample Jaalin and 16.7% shaigiya and 12.5% 
Bedaria .  
 
 
 
Table(6) Level of education 
 
 
 
  level of education Total 
  Primary Secondary under graduate 
studies 
Post graduate 
studies 
label Name control 3 4 6 2 15 
Sample 3 9 8 4 24 
Total 6 13 14 6 39 
 
From table (6) and table (27) According to the Analysis of Variance, there were no 
significant differences between the level of education  groups in the mean  F(1.37 ) = .057 
  p> .05. 
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Table (7) Tobacco use 
 
 
  Tobacco use Total 
  yes no 
label Name control 4 11 15 
Sample 15 9 24 
Total 19 20 39 
 
 
From table (7) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 5.124 p<  05. 
 
 
Table(8) History of premature in the family 
 
 
Count 
    
  Is there is history of premature gray 
hair in the family? 
Total 
  yes no 
label Name control 0 15 15 
Sample 20 4 24 
Total 20 19 39 
 
 
From table (8) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 71.154  p< .05. 
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Table(9) Exercises  
 
 
  Do you have an active lifestyle Total 
  yes no 
label Name control 9 6 15 
Sample 10 14 24 
Total 19 20 39 
 
 
From table (9) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) = 1.217 p> 
.05. 
 
 
Table(10) Time of Exercise Now 
 
label Name * Time of Exercise Now Crosstabulation 
  Time of Exercise Now Total 
  Little or no 
exercise 
Light exercise Moderate 
exercise 
Hard exercise Very 
hard 
exercis
e 
label Name control 4 5 1 4 1 15 
Sample 13 3 4 4 0 24 
Total 17 8 5 8 1 39 
 
 
From table (10) and table (27) According to the Analysis of Variance, there were 
no significant differences between the groups in the mean  F(1.37 ) = 1.924  p> 
05. 
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Table(11) Time of Exercise past 
 
 
 
From table (11) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) = 2.568  p> 
.05. 
 
 
Table(12) Milk in diet  
 
 
  DO YOU HAVE MILK IN YOUR DIET Total 
  yes no 
label Name control 15 0 15 
Sample 17 7 24 
Total 32 7 39 
 
 
From table (12) and table (27) According to the Analysis of Variance, there were  
significant differences between the groups in the mean  F(1.37 ) = 5.860 p< .05. 
 
 
 
 
 
label Name * Time of Exercise Past Crosstabulation 
  Time of Exercise Past Total 
  Little or no 
exercise 
Light exercise Moderate 
exercise 
Hard exercise Very hard 
exercise 
label Name control 3 2 2 7 1 15 
Sample 12 3 2 4 3 24 
Total 15 5 4 11 4 39 
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Table(13) Consumption of milk per day 
 
 
label Name * CONSUMPTION OF MILK PER DAY Crosstabulation 
Count 
      
  CONSUMPTION OF MILK PER DAY Total 
  0 1 2 3 
label Name control 0 4 6 5 15 
Sample 7 9 5 3 24 
Total 7 13 11 8 39 
 
 
From table (13) and table (27) According to the Analysis of Variance, there were  
significant differences between the groups in the mean  F(1.37 ) = 8.574 p< 05. 
 
 
 
Table(14) Is there cheese in your diet? 
 
label Name * IS THERE CHEESE IN YOUR DIET?  Crosstabulation 
Count 
    
  IS THERE CHEESE IN YOUR 
DIET?  
Total 
  yes no 
label Name control 15 0 15 
Sample 17 7 24 
Total 32 7 39 
 
 
From table (14) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 5.860 p< .05. 
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Table(15)   Is there yogurt in your diet 
 
 
 
Count 
    
  IS THERE YOGURT IN YOUR 
DIET 
Total 
  yes no 
label Name control 15 0 15 
Sample 18 6 24 
Total 33 6 39 
 
 
From table (15) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 4.744  p< .05. 
 
Table(16) 
Total consumption of yogurt per week 
 
 
Count 
    
  label Name Total 
  control Sample 
TOTAL CONSUMPTION 
OF YOGURT PER WEEK 
0 0 6 6 
1 1 8 9 
2 4 5 9 
3 2 5 7 
6 2 0 2 
7 6 0 6 
Total 15 24 39 
 
 
From table (16) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 31.937 p< .05. 
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Table ( 17 ) How much coffe do you drink ? 
 
 
 
HOW MUCH COFFEE DO YOU DRINK?  
Count 
    
  label Name Total 
  control Sample 
HOW MUCH COFFEE DO 
YOU DRINK? 
0 6 0 6 
1 4 12 16 
2 5 8 13 
3 0 2 2 
4 0 1 1 
6 0 1 1 
Total 15 24 39 
 
From table (17) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 6.250  p< .05. 
 
Table(18) 
 
How much tea do you drink? 
 
 
Count 
    
  label Name Total 
  control Sample 
HOW MUCH TEA DO 
YOU DRINK? 
1 5 3 8 
2 4 1 5 
3 3 12 15 
4 3 8 11 
Total 15 24 39 
 
From table (18) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 5.142 p< .05. 
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Table(19) 
 
How much water do you drink ? 
 
HOW MUCH WATER DO YOU DRINK  
Count 
    
  label Name Total 
  control Sample 
HOW MUCH WATER DO 
YOU DRINK 
3 0 1 1 
4 1 1 2 
5 1 6 7 
6 0 3 3 
7 4 5 9 
8 4 5 9 
9 3 1 4 
10 2 1 3 
12 0 1 1 
Total 15 24 39 
 
From table (19) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) = 2.721  p> 
.05. 
 
Table(20) 
Have you ever suffered from excessive stress 
 
label Name * HAVE YOU EVER SUFFERED FROM EXCESSIVE STRESS Crosstabulation 
Count 
    
  HAVE YOU EVER SUFFERED 
FROM EXCESSIVE STRESS 
Total 
  yes no 
label Name control 4 11 15 
Sample 16 8 24 
Total 20 19 39 
 
From table (20) and table (27) According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  F(1.37 ) = 6.610  p< .05. 
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Table(21) 
Do you have a family history of heart disease ? 
 
 
 
Count 
    
  DO YOU HAVE A FAMILY 
HISTORY OF HEART DISEASE 
Total 
  yes no 
label Name control 1 14 15 
Sample 9 15 24 
Total 10 29 39 
 
From table (21) and table (27) According to the Analysis of Variance, there were 
significant differences between the groups in the mean  F(1.37 ) = 4.951 p< .05 
 
 
Table(22)  
Do you have a family history of osteoporosis ? 
 
 
 
 
Count 
    
  DO YOU HAVE A FAMILY 
HISTORY OF OSTEOPOROSIS 
Total 
  yes no 
label Name control 2 13 15 
Sample 8 16 24 
Total 10 29 39 
 
From table (22) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) = 1.933  p> 
.05. 
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Table(23) 
 
Family history of other Bone disorders 
 
 
 
label Name * DO YOU HAVE A FAMILY HISTORY OF ANY OTHER BONE DISORDER  
Count 
    
  DO YOU HAVE A FAMILY HISTORY 
OF ANY OTHER BONE DISORDER 
Total 
  yes no 
label Name control 2 13 15 
Sample 10 14 24 
Total 12 27 39 
 
 
From table (23) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) = 3.624  p> 
.05. 
 
 
Table(24) 
Have you recently lost weight? 
 
 
 
Count 
    
  HAVE YOU RECENTLY LOST 
WEIGHT? 
Total 
  yes no 
label Name control 3 12 15 
Sample 7 17 24 
Total 10 29 39 
 
From table (24) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) =  .390 p> 
.05. 
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Table(25) 
Have you recently had or do you have any back pain ? 
 
 
Count 
    
  HAVE YOU RECENTLY HAD 
OR DO YOU HAVE ANY BACK 
PAIN 
Total 
  yes no 
label Name control 2 13 15 
Sample 15 9 24 
Total 17 22 39 
 
 
From table (25) and table (27) According to the Analysis of Variance, there were 
no significant differences between the  groups in the mean  F(1.37 ) =11.220   p< 
.05. 
 
Table(26) 
Have you had any of the following medical conditions? A. 
Rheumatoid arthritis. 
 
 
 
label Name * Have you had any of the following medical conditions? A. Rheumatoid arthritis.  
Crosstabulation 
Count 
    
  Have you had any of the following 
medical conditions? A. Rheumatoid 
arthritis.  
Total 
  yes no 
label Name control 0 15 15 
Sample 12 12 24 
Total 12 27 39 
 
 
From table (26) and table (27) According to the Analysis of Variance, there were 
significant differences between the   groups in the mean  F(1.37 ) = 14.231p< 05. 
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Table(27) Analysis of variance ( ANOVA ) 
 
 
ANOVA 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
Age 4.001 1 4.001 .379 .542 
Height 31.878 1 31.878 .722 .401 
Weight 20.083 1 20.083 .254 .617 
body mass index 12.924 1 12.924 1.311 .260 
level of education .052 1 .052 .057 .813 
Tobacco use 1.185 1 1.185 5.124 .030 
Is there is history of premature gray 
hair in the family? 
6.410 1 6.410 71.154 .000 
Do you have an active lifestyle .310 1 .310 1.217 .277 
Time of Exercise Now 3.052 1 3.052 1.924 .174 
Time of Exercise Past 5.544 1 5.544 2.568 .118 
DO YOU HAVE MILK IN YOUR 
DIET 
.785 1 .785 5.860 .021 
CONSUMPTION OF MILK PER 
DAY 
7.477 1 7.477 8.574 .006 
IS THERE CHEESE IN YOUR 
DIET? 
.785 1 .785 5.860 .021 
IS THERE YOGURT IN YOUR 
DIET 
.577 1 .577 4.744 .036 
TOTAL CONSUMPTION OF 
YOGURT PER WEEK 
96.006 1 96.006 31.937 .000 
HOW MUCH COFFEE DO YOU 
DRINK? 
7.477 1 7.477 6.250 .017 
HOW MUCH TEA DO YOU 
DRINK? 
5.544 1 5.544 5.142 .029 
HOW MUCH WATER DO YOU 
DRINK 
9.698 1 9.698 2.721 .108 
HAVE YOU EVER SUFFERED 
FROM EXCESSIVE STRESS 
1.477 1 1.477 6.610 .014 
DO YOU HAVE A FAMILY 
HISTORY OF HEART DISEASE 
.878 1 .878 4.951 .032 
DO YOU HAVE A FAMILY 
HISTORY OF OSTEOPOROSIS 
.369 1 .369 1.933 .173 
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DO YOU HAVE A FAMILY 
HISTORY OF ANY OTHER 
BONE DISORDER 
.741 1 .741 3.624 .065 
HAVE YOU RECENTLY LOST 
WEIGHT? 
.078 1 .078 .390 .536 
HAVE YOU RECENTLY HAD 
OR DO YOU HAVE ANY BACK 
PAIN 
2.231 1 2.231 11.220 .002 
Have you had any of the following 
medical conditions? A. Rheumatoid 
arthritis. 
2.308 1 2.308 14.231 .001 
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5 –Discussion 
          Gray hair is a phenomenon usually caused by aging 
process. Also, it is affected by some environmental and 
genetic factors. Although in most cases canities is 
inherited in an autosomal dominant manner, some 
environmental factors accelerate this process [6, 86, 87] . The 
results of this study show that there was a relationship 
between premature gray hair and Calcium concentration. 
However, there was  significant difference between the 
mean Calcium concentrations in the case group compared 
to the normal one.  
          Table 1 shows that concentrations of calcium in 
gray hairs were higher than those in black hairs for males 
(𝑃< 0.05). 
          That result is inconsistent with the study of Yueh et 
al  Who found that the  concentrations of calcium metal 
elements in gray hairs are lower than in black hairs . [69] 
            but it agrees with the study of M. Dlugaszek, et al  
who studied the concentration of magnesium, calcium and 
trace elements distribution in serum, erythrocytes, and 
hair of patients with chronic renal failure he found that 
the concentration of calcium > 2 000 µg/g  was markedly 
higher when compared to the normal group . While in the 
hair of women with osteomalacia the content of Calcium  
> 2 000 µg/g was significantly different from that of the 
normal group . and was significantly lower in the case of 
Ca in serum . [84] Another study has provided evidence of  
a low level of calcium and  vitamin D3 in the blood 
causes premature gray hair .  
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          An insufficient amount of calcium in your diet will 
generally not cause hypocalcemia. This is because normal 
amounts of calcium in the blood are so critical to many 
vital body functions of the nerves, muscles, brain and 
heart, that your body will pull calcium from the bones as 
needed to maintain normal blood calcium levels. This 
enables important processes in the body to continue. 
However, ongoing dietary calcium deficiency can 
eventually lead to thinning of the bones and osteoporosis 
because calcium stores in the bones are not replaced as 
they are used by the body . [86]  
          There  are several factors that influence peak bone 
mass  These include heredity, sex, nutrition , (physical 
activity, body mass) and some risk factors (smoking, 
excessive alcohol intake, etc.). 
          According to the Analysis of Variance, there were 
significant differences between the  groups in the mean  
of Tobbaco use table (7) and  calcium intake in diet : table 
(12) , (13) , (14) , (15). And drink the coffee  and tea table 
( 17 ) , (18) and Excessive Stress Table (20) . 
          Combining Previous studies and result obtained in 
this study with each suggested an inverse relationship 
between  bone mineral density ( BMD ) and the 
concentration of calcium in the gray hair . 
 
          I also found relationship of a family history of heart 
disease table (21). and back Pain Table (25) and A. 
Rheumatoid arthritis table (26) . While BMI and a family 
history of Osteoporosis table Table (22) According to the 
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Analysis of  Variance, there were no significant  
differences between the  groups . 
 
Conclusion 
The findings of this study revealed that concentrations of  
calcium  metal elements in gray hairs were higher than in black 
hairs with significant differences between black and gray hairs 
(𝑃< 0.05). 
 
Recommendations 
Need for further studies 
Consume daily at least 1.5 Pint of milk and dairy produced with 
reduced fat content 
 
Choose vegetables with high calcium content . 
 
 Ensure sufficient intake of vitamin D (fish, livers, milk), 
vitamin K (leafy vegetables, livers, fish) and vitamin C . 
 
 
Do not smoke  and Reducing drinking coffe and tea . 
 
A thorough examination of the heart and kidney functions of 
patients with premature graying . 
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